Clinical studies recruiting near Palma

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Hospital Universitario Virgen de la Arrixaca · Daiichi Sankyo · NCT07022483 Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Phase N/A · Hospital Son Espases · Spanish Oncology Genito-Urinary Group · NCT06724159 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Hospital Son Llàtzer · Pfizer · NCT06758401 Spanish Series of Patients Treated With the Radionuclide Lutetium177
Phase N/A · Hospital Unviersitari Son Espases · Sociedad Española de Medicina Nuclear e Imagen Molecular · NCT04949282 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hospital Universitario Son Espases · Hoffmann-La Roche · NCT06793215 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 Spanish Registry of Esophagogastric Cancer
Phase N/A · Hospital Universitario Son Espases · Fundación Sociedad Española de Oncologia Médica · NCT04958720 Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management
Phase 2 · Hospital Son Espases · SOLTI Breast Cancer Research Group · NCT07371585 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Hospital Universitario de Gran Canarias Dr. Negrín · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Hospital Insular de Gran Canaria · Eli Lilly and Company · NCT06890598 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · Hospital Son Espases · Hoffmann-La Roche · NCT07284121 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Son Espases University Hospital · Regeneron Pharmaceuticals · NCT06091865 Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
Phase 2 · Hospital de Son Espases · Fundación GECP · NCT05398094 Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
Phase N/A · Hospital Universitario Son Espases · RECORDATI GROUP · NCT04176523 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Hospital Universitari Son Espases · Pfizer · NCT07144280 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0183 · Celgene · NCT05519085 Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Phase 2/Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05948943 International Chronic Myeloid Leukemia Pediatric Study
Phase N/A · Officina Proyectos SEHOP · Poitiers University Hospital · NCT01281735 A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcuta
Phase N/A · Hospital Universitari Son Espases /ID# 276349 · AbbVie · NCT07284342 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · Hospital Fundacion Son Llatzer · Bristol-Myers Squibb · NCT05489705 Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously
Phase 3 · Hospital Universitari de Gran Canària Doctor Negrín · Fundación GECP · NCT06431633 A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06564038 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site ES014 · Incyte Corporation · NCT07522073 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Hospital Son Llàtzer · Bristol-Myers Squibb · NCT06561386 eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (CO
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07177339 Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
Phase 4 · Hospital Universitario de Gran Canaria Doctor Negrín · Hospital Universitario de Fuenlabrada · NCT05250648 Thoracic Tumours Register
Phase N/A · H. Insular de Gran Canarias · Spanish Lung Cancer Group · NCT02941458 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · H. Universitario Insular de Canarias · Boehringer Ingelheim · NCT07472517 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557

Look up another city

Look up another condition